These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15657730)

  • 1. [Facial pigmentation following therapy with terbinafine].
    Breuer K; Völker B; Gutzmer R; Kapp A; Werfel T
    Hautarzt; 2005 Nov; 56(11):1056-9. PubMed ID: 15657730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Oral terbinafine-induced plantar pustular psoriasis].
    Le Guyadec T; Saint-Blancard P; Bosonnet S; Le Vagueresse R; Lanternier G
    Ann Dermatol Venereol; 2000 Mar; 127(3):279-81. PubMed ID: 10804301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple onychocryptosis following treatment of onychomycosis with oral terbinafine.
    Weaver TD; Jespersen DL
    Cutis; 2000 Sep; 66(3):211-2. PubMed ID: 11006857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible agranulocytosis associated with oral terbinafine in a pediatric patient.
    Aguilar C; Mueller KK
    J Am Acad Dermatol; 2001 Oct; 45(4):632-4. PubMed ID: 11568763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypersensitivity syndrome reaction to oral terbinafine.
    Gupta AK; Porges AJ
    Australas J Dermatol; 1998 Aug; 39(3):171-2. PubMed ID: 9737044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral terbinafine-induced bullous pemphigoid.
    Aksakal BA; Ozsoy E; Arnavut O; Ali Gürer M
    Ann Pharmacother; 2003 Nov; 37(11):1625-7. PubMed ID: 14565807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent updates in oral terbinafine: its use in onychomycosis and tinea capitis in the US.
    Van Duyn Graham L; Elewski BE
    Mycoses; 2011 Nov; 54(6):e679-85. PubMed ID: 21668517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facial hyperpigmentation. amiodarone-induced hyperpigmentation.
    e Silva LP; Luís F; Cabrera H
    Am Fam Physician; 2008 Dec; 78(11):1297-8. PubMed ID: 19069023
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of dermatophyte onychomycosis with three pulses of terbinafine (500 mg day for a week).
    Takahata Y; Hiruma M; Shiraki Y; Tokuhisa Y; Sugita T; Muto M
    Mycoses; 2009 Jan; 52(1):72-6. PubMed ID: 18444971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rhabdomyolisis and terbinafine].
    Gallego Peris A; Sanfélix Gimeno G; Palop Larrea V; Sanfélix Genovés J
    Med Clin (Barc); 2006 Nov; 127(20):799. PubMed ID: 17198674
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial.
    Auvinen T; Tiihonen R; Soini M; Wangel M; Sipponen A; Jokinen JJ
    Br J Dermatol; 2015 Oct; 173(4):940-8. PubMed ID: 26036329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral antifungal-exacerbated inflammatory flare-up reactions of dermatomycosis : case reports and review of the literature.
    Nikkels AF; Nikkels-Tassoudji N; Piérard GE
    Am J Clin Dermatol; 2006; 7(5):327-31. PubMed ID: 17007544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute generalized exanthematous pustulosis induced by terbinafine.
    Taberner R; Puig L; Gilaberte M; Alomar A
    Eur J Dermatol; 2003; 13(3):313-4. PubMed ID: 12805000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Terbinafine-induced subacute cutaneous lupus erythematosus.
    Hivnor CM; Hudkins ML; Bonner B
    Cutis; 2008 Feb; 81(2):156-7. PubMed ID: 18441768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyperpigmentation of the face].
    Dissemond J; Franckson T; Fitz G; Hillen U; Goos M
    Hautarzt; 2003 Oct; 54(10):994-8. PubMed ID: 14513255
    [No Abstract]   [Full Text] [Related]  

  • 16. Persistent severe amiodarone-induced photosensitivity.
    Yones SS; O'Donoghue NB; Palmer RA; Menagé Hdu P; Hawk JL
    Clin Exp Dermatol; 2005 Sep; 30(5):500-2. PubMed ID: 16045677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terbinafine induced pityriasis rosea-like eruption.
    George A; Bhatia A; Kanish B; Williams A
    Indian J Pharmacol; 2015; 47(6):680-1. PubMed ID: 26729964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute generalized exanthematous pustulosis induced by the antifungal terbinafine: case report and review of the literature.
    Beltraminelli HS; Lerch M; Arnold A; Bircher AJ; Haeusermann P
    Br J Dermatol; 2005 Apr; 152(4):780-3. PubMed ID: 15840114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxic epidermal necrolysis and erythema multiforme following therapy with terbinafine.
    Carstens J; Wendelboe P; Søgaard H; Thestrup-Pedersen K
    Acta Derm Venereol; 1994 Sep; 74(5):391-2. PubMed ID: 7817681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
    Gupta AK; Gover MD; Lynde CW
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.